Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York
The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccina...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2021-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_50fa0d29ba4d4c1a8081347a7b95f2bc | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Tamar A. Smith-Norowitz |e author |
| 700 | 1 | 0 | |a Jonathan I. Silverberg |e author |
| 700 | 1 | 0 | |a Esther M. Norowitz |e author |
| 700 | 1 | 0 | |a Stephan Kohlhoff |e author |
| 700 | 1 | 0 | |a Margaret R Hammerschlag |e author |
| 245 | 0 | 0 | |a Factors impacting vaccine hesitancy toward Coronavirus disease-19 (COVID-19) vaccination in Brooklyn, New York |
| 260 | |b Taylor & Francis Group, |c 2021-11-01T00:00:00Z. | ||
| 500 | |a 2164-5515 | ||
| 500 | |a 2164-554X | ||
| 500 | |a 10.1080/21645515.2021.1948786 | ||
| 520 | |a The Coronavirus disease-2019 (COVID-19) pandemic led to the development of several candidate vaccines. However, current research suggests that the potential of successful vaccines is tempered by vaccine skepticism or hesitancy. If vaccine efficacy is 80%, then the herd immunity required from vaccination is about 75-90%. The aim of the current study was to study factors impacting COVID-19 vaccine hesitancy in a representative sample of adults (age≥18 years) in a COVID-19 hotspot Abbreviations: COVID-19: coronavirus disease-19 | ||
| 546 | |a EN | ||
| 690 | |a covid-19 | ||
| 690 | |a covid-19 vaccine | ||
| 690 | |a seasonal influenza vaccine | ||
| 690 | |a vaccine hesitancy | ||
| 690 | |a new york | ||
| 690 | |a Immunologic diseases. Allergy | ||
| 690 | |a RC581-607 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4013-4014 (2021) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/21645515.2021.1948786 | |
| 787 | 0 | |n https://doaj.org/toc/2164-5515 | |
| 787 | 0 | |n https://doaj.org/toc/2164-554X | |
| 856 | 4 | 1 | |u https://doaj.org/article/50fa0d29ba4d4c1a8081347a7b95f2bc |z Connect to this object online. |